Show notes
Boston. San Francisco. Beijing? The global biotech industry has long been concentrated in a handful of cities. But which emerging hubs could become dominant forces in biotech in the decades ahead? In this week’s episode of “The Top Line,” Fierce Biotech’s Darren Incorvaia and Will Maddox discuss a new Fierce special report identifying five cities with the potential to become major forces in the global biotech industry.
Transcript
Transcript not available for this episode yet.
More from The Top Line
GSK’s first lung cancer approval, a new IPO path and more
Jul 24, 202611 min
Why modern clinical trials need a finance-first strategy (Sponsored)
Jul 20, 202617 min
Decision readiness is the next AI advantage (Sponsored)
Jul 13, 202618 min
A $10B deal, China trial scrutiny and highlights from ADA 2026
Jul 10, 202624 min
The deal before the deal
Jun 26, 202641 min